3-(3-fluorophenyl)-N-[[4-(methoxymethyl)piperidin-4-yl]methyl]-2-(5-methyltetrazol-1-yl)propanamide
C19H27FN6O2 — CID 120888827
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(3-fluorophenyl)-N-[[4-(methoxymethyl)piperidin-4-yl]methyl]-2-(5-methyltetrazol-1-yl)propanamide
3-(3-fluorophenyl)-N-[[4-(methoxymethyl)piperidin-4-yl]methyl]-2-(5-methyltetrazol-1-yl)propanamide (PubChem CID 120888827) has the molecular formula C19H27FN6O2 and a molecular weight of 390.46 g/mol. Its IUPAC name is 3-(3-fluorophenyl)-N-[[4-(methoxymethyl)piperidin-4-yl]methyl]-2-(5-methyltetrazol-1-yl)propanamide.
Molecular Properties
| Compound Name | 3-(3-fluorophenyl)-N-[[4-(methoxymethyl)piperidin-4-yl]methyl]-2-(5-methyltetrazol-1-yl)propanamide |
|---|---|
| PubChem CID | 120888827 |
| Molecular Formula | C19H27FN6O2 |
| Molecular Weight | 390.46 g/mol |
| Exact Mass | 390.22 |
| IUPAC Name | 3-(3-fluorophenyl)-N-[[4-(methoxymethyl)piperidin-4-yl]methyl]-2-(5-methyltetrazol-1-yl)propanamide |
| SMILES | COCC1(CNC(=O)C(Cc2cccc(F)c2)n2nnnc2C)CCNCC1 |
| InChI | InChI=1S/C19H27FN6O2/c1-14-23-24-25-26(14)17(11-15-4-3-5-16(20)10-15)18(27)22-12-19(13-28-2)6-8-21-9-7-19/h3-5,10,17,21H,6-9,11-13H2,1-2H3,(H,22,27) |
| InChIKey | URDGHNZMPDROMO-UHFFFAOYSA-N |
| XLogP | 1.04 |
| TPSA | 93.96 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 390.46 |
| LogP ≤ 5 | 1.04 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120888827 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.